Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
Clinical trial NCT01891968 · COMPLETED
Trial details
- NCT number
- NCT01891968
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-07
- Primary completion
- 2017-01-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.